Weitz & Luxenberg trial attorney Danny Kraft, Jr. is one of the presenters scheduled for an upcoming seminar sponsored by the New Jersey Institute for…
Read MoreFirm News
Category: Drugs & Devices
W&L Taking Penumbra Recalled JET 7 Catheters with Xtra Flex Technology Cases
According to the U.S. Food and Drug Administration (FDA), the medical device manufacturer Penumbra issued an urgent voluntary recall of the Penumbra JET 7…
Category: Mesothelioma, Our Firm
W&L Attorneys Participate in N.Y. Asbestos Litigation Conference
This year’s New York Asbestos Conference was co-chaired by Charles Ferguson, chair of Weitz & Luxenberg’s Mesothelioma and Asbestos Practice Group. Three other attorneys…
Category: Our Firm
Attorneys Gold and McDonough Speak at NJAJ
Attorneys Danielle Gold and Brendan McDonough, from our Drug and Medical Device Litigation unit, are presenting at the New Jersey Association for Justice (NJAJ)…
Category: Our Firm
U.S. News & World Report Recognizes W&L as “Best Law Firm”
Weitz & Luxenberg has been recognized by U.S. News & World Report and Best Lawyers magazine as one of the Best Law Firms in…
Category: Mesothelioma
New Mesothelioma Treatment Approved by FDA
The U.S. Food and Drug Administration (FDA) has approved a new drug therapy for treating mesothelioma which combines the use of two existing drugs.[cite…